To evaluate the value of employing artificial intelligence (AI)-assisted CT pulmonary angiography (CTPA) for patients with chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic disease (CTED). A single-center, retrospective analysis of 350 sequential patients with right heart catheterization (RHC)-confirmed CTEPH, CTED, and normal controls was conducted. Parameters such as the main pulmonary artery diameter (MPAd), the ratio of MPA to ascending aorta diameter (MPAd/AAd), the ratio of right to left ventricle diameter (RVd/LVd), and the ratio of RV to LV volume (RVv/LVv) were evaluated using automated AI software and compared with manual analysis. The reliability was assessed through an intraclass correlation coefficient (ICC) analysis. The diagnostic accuracy was determined using receiver-operating characteristic (ROC) curves. Compared to CTED and control groups, CTEPH patients were significantly more likely to have elevated automatic CTPA metrics (all p < 0.001, respectively). Automated MPAd, MPAd/Aad, and RVv/LVv had a strong correlation with mPAP (r = 0.952, 0.904, and 0.815, respectively, all p < 0.001). The automated and manual CTPA analyses showed strong concordance. For the CTEPH and CTED categories, the optimal area under the curve (AU-ROC) reached 0.939 (CI: 0.908-0.969). In the CTEPH and control groups, the best AU-ROC was 0.970 (CI: 0.953-0.988). In the CTED and control groups, the best AU-ROC was 0.782 (CI: 0.724-0.840). Automated AI-driven CTPA analysis provides a dependable approach for evaluating patients with CTEPH, CTED, and normal controls, demonstrating excellent consistency and efficiency. Question Guidelines do not advocate for applying treatment protocols for CTEPH to patients with CTED; early detection of the condition is crucial. Findings Automated CTPA analysis was feasible in 100% of patients with good agreement and would have added information for early detection and identification. Clinical relevance Automated AI-driven CTPA analysis provides a reliable approach demonstrating excellent consistency and efficiency. Additionally, these noninvasive imaging findings may aid in treatment stratification and determining optimal intervention directed by RHC.

The clinical benefits of neoadjuvant chemoimmunotherapy (NACI) are demonstrated in patients with bladder cancer (BCa); however, more than half fail to achieve a pathological complete response (pCR). This study utilizes multi-center cohorts of 2322 patients with pathologically diagnosed BCa, collected between January 1, 2014, and December 31, 2023, to explore the correlation between tumor budding (TB) status and NACI response and disease prognosis. A deep learning model is developed to noninvasively evaluate TB status based on CT images. The deep learning model accurately predicts the TB status, with area under the curve values of 0.932 (95% confidence interval: 0.898-0.965) in the training cohort, 0.944 (0.897-0.991) in the internal validation cohort, 0.882 (0.832-0.933) in external validation cohort 1, 0.944 (0.908-0.981) in the external validation cohort 2, and 0.854 (0.739-0.970) in the NACI validation cohort. Patients predicted to have a high TB status exhibit a worse prognosis (p < 0.05) and a lower pCR rate of 25.9% (7/20) than those predicted to have a low TB status (pCR rate: 73.9% [17/23]; p < 0.001). Hence, this model may be a reliable, noninvasive tool for predicting TB status, aiding clinicians in prognosis assessment and NACI strategy formulation.

The accurate classification of lung nodules is critical to achieving personalized lung cancer treatment and prognosis prediction. The treatment options for lung cancer and the prognosis of patients are closely related to the type of lung nodules, but there are many types of lung nodules, and the distinctions between certain types are subtle, making accurate classification based on traditional medical imaging technology and doctor experience challenging. In this study, a novel method was used to analyze quantitative features in CT images using CT radiomics to reveal the characteristics of pulmonary nodules, and then feature fusion was used to integrate radiomics features and deep learning features to improve the accuracy of classification. This paper proposes a fusion feature pulmonary nodule classification method that fuses radiomics features with deep learning neural network features, aiming to automatically classify different types of pulmonary nodules (such as Malignancy, Calcification, Spiculation, Lobulation, Margin, and Texture). By introducing the Discriminant Correlation Analysis feature fusion algorithm, the method maximizes the complementarity between the two types of features and the differences between different classes. This ensures interaction between the information, effectively utilizing the complementary characteristics of the features. The LIDC-IDRI dataset is used for training, and the fusion feature model has been validated for its advantages and effectiveness in classifying multiple types of pulmonary nodules. The experimental results show that the fusion feature model outperforms the single-feature model in all classification tasks. The AUCs for the tasks of classifying Calcification, Lobulation, Margin, Spiculation, Texture, and Malignancy reached 0.9663, 0.8113, 0.8815, 0.8140, 0.9010, and 0.9316, respectively. In tasks such as nodule calcification and texture classification, the fusion feature model significantly improved the recognition ability of minority classes. The fusion of radiomics features and deep learning neural network features can effectively enhance the overall performance of pulmonary nodule classification models while also improving the recognition of minority classes when there is a significant class imbalance.

In cone beam computed tomography(CBCT)-guided adaptive radiotherapy, rapid and precise segmentation of organs-at-risk(OARs)is essential for accurate dose verification and online replanning. The quality of CBCT images obtained with current onboard CBCT imagers and clinical imaging protocols, however, is often compromised by artifacts such as scatter and motion, particularly for thoracic CBCTs. These artifacts not only degrade image contrast but also obscure anatomical boundaries, making accurate segmentation on CBCT images significantly more challenging compared to planning CT images. To address these persistent challenges, we propose a novel multi-channel conditional consistency diffusion model(MCCDM)for segmentation of OARs in thoracic CBCT images (CBCT-MCCDM), which harnesses its domain transfer capabilities to improve segmentation accuracy across different imaging modalities. By jointly training the MCCDM with CT images and their corresponding masks, our framework enables an end-to-end mapping learning process that generates accurate segmentation of OARs.&#xD;This CBCT-MCCDM was used to delineate esophagus, heart, the left and right lungs, and spinal cord on CBCT images from each patient with lung cancer. We quantitatively evaluated our approach by comparing model-generated contours with ground truth contours from 33 patients with lung cancer treated with 5-fraction stereotactic body radiation therapy (SBRT), demonstrating its potential to enhance segmentation accuracy despite the presence of challenging CBCT artifacts. The proposed method was evaluated using average Dice similarity coefficients (DSC), sensitivity, specificity, 95th Percentile Hausdorff Distance (HD95), and mean surface distance (MSD) for each of the five OARs. The method achieved average DSC values of 0.82, 0.88, 0.95, 0.96, and 0.96 for the esophagus, heart, left lung, right lung, and spinal cord, respectively. Sensitivity values were 0.813, 0.922, 0.956, 0.958, and 0.929, respectively, while specificity values were 0.991, 0.994, 0.996, 0.996, and 0.995, respectively. We compared the proposed method with two state-of-art methods, CBCT-only method and U-Net, and demonstrated that the proposed CBCT-MCCDM.

Low-dose colchicine (0.5 mg once daily) reduces the risk of major cardiovascular events in coronary disease, but its mechanism of action is not yet fully understood. We investigated whether low-dose colchicine is associated with changes in pericoronary inflammation and plaque composition in patients with chronic coronary disease. We performed a cross-sectional, nationwide, subanalysis of the Low-Dose Colchicine 2 Trial (LoDoCo2, n=5522). CT angiography studies were performed in 151 participants randomised to colchicine or placebo coronary after a median treatment duration of 28.2 months. Pericoronary adipose tissue (PCAT) attenuation measurements around proximal coronary artery segments and quantitative plaque analysis for the entire coronary tree were performed using artificial intelligence-enabled plaque analysis software. Median PCAT attenuation was not significantly different between the two groups (-79.5 Hounsfield units (HU) for colchicine versus -78.7 HU for placebo, p=0.236). Participants assigned to colchicine had a higher volume (169.6 mm³ vs 113.1 mm³, p=0.041) and burden (9.6% vs 7.0%, p=0.035) of calcified plaque, and higher volume of dense calcified plaque (192.8 mm³ vs 144.3 mm³, p=0.048) compared with placebo, independent of statin therapy. Colchicine treatment was associated with a lower burden of low-attenuation plaque in participants on a low-intensity statin, but not in those on a high-intensity statin (p_interaction=0.037). Pericoronary inflammation did not differ among participants who received low-dose colchicine compared with placebo. Low-dose colchicine was associated with a higher volume of calcified plaque, particularly dense calcified plaque, which is considered a feature of plaque stability.

This study aims to develop and validate a multiregional radiomics model to predict pathological complete response (pCR) to neoadjuvant chemoimmunotherapy in non-small cell lung cancer (NSCLC), and further evaluate the performance of the model in different specific subgroups (N2 stage and anti-PD-1/PD-L1). 216 patients with NSCLC who underwent neoadjuvant chemoimmunotherapy followed by surgical intervention were included and assigned to training and validation sets randomly. From pre-treatment baseline CT, one intratumoral (T) and two peritumoral regions (P₃: 0-3 mm; P₆: 0-6 mm) were extracted. Five radiomics models were developed using machine learning algorithms to predict pCR, utilizing selected features from intratumoral (T), peritumoral (P₃, P₆), and combined intra- and peritumoral regions (T + P₃, T + P₆). Additionally, the predictive efficacy of the optimal model was specifically assessed for patients in the N2 stage and anti-PD-1/PD-L1 subgroups. A total of 51.4 % (111/216) of patients exhibited pCR following neoadjuvant chemoimmunotherapy. Multivariable analysis identified that only the T + P₃ radiomics signature served as independent predictor of pCR (P < 0.001). The multiregional radiomics model (T + P₃) exhibited superior predictive performance for pCR, achieving an area under the curve (AUC) of 0.75 in the validation cohort. Furthermore, this multiregional model maintained robust predictive accuracy in both N2 stage and anti-PD-1/PD-L1 subgroups, with an AUC of 0.829 and 0.833, respectively. The proposed multiregional radiomics model showed potential in predicting pCR in NSCLC after neoadjuvant chemoimmunotherapy, and demonstrated good predictive performance in different specific subgroups. This capability may assist clinicians in identifying suitable candidates for neoadjuvant chemoimmunotherapy and promote the advancement in precision therapy.

Cone-Beam Computed Tomography (CBCT) is essential in medical imaging, and the Feldkamp-Davis-Kress (FDK) algorithm is a popular choice for reconstruction due to its efficiency. However, FDK is susceptible to noise and artifacts. While recent deep learning methods offer improved image quality, they often increase computational complexity and lack the interpretability of traditional methods. In this paper, we introduce an enhanced FDK-based neural network that maintains the classical algorithm's interpretability by selectively integrating trainable elements into the cosine weighting and filtering stages. Recognizing the challenge of a large parameter space inherent in 3D CBCT data, we leverage wavelet transformations to create sparse representations of the cosine weights and filters. This strategic sparsification reduces the parameter count by $93.75\%$ without compromising performance, accelerates convergence, and importantly, maintains the inference computational cost equivalent to the classical FDK algorithm. Our method not only ensures volumetric consistency and boosts robustness to noise, but is also designed for straightforward integration into existing CT reconstruction pipelines. This presents a pragmatic enhancement that can benefit clinical applications, particularly in environments with computational limitations.

The standard approach to diagnosing idiopathic pulmonary fibrosis (IPF) includes identifying the usual interstitial pneumonia (UIP) pattern via high resolution computed tomography (HRCT) or lung biopsy and excluding known causes of interstitial lung disease (ILD). However, limitations of manual interpretation of lung imaging, along with other reasons such as lack of relevant knowledge and non-specific symptoms have hindered the timely diagnosis of IPF. This review proposes the definition of early IPF, emphasizes the diagnostic urgency of early IPF, and highlights current diagnostic strategies and future prospects for early IPF. The integration of artificial intelligence (AI), specifically machine learning (ML) and deep learning (DL), is revolutionizing the diagnostic procedure of early IPF by standardizing and accelerating the interpretation of thoracic images. Innovative bronchoscopic techniques such as transbronchial lung cryobiopsy (TBLC), genomic classifier, and endobronchial optical coherence tomography (EB-OCT) provide less invasive diagnostic alternatives. In addition, chest auscultation, serum biomarkers, and susceptibility genes are pivotal for the indication of early diagnosis. Ongoing research is essential for refining diagnostic methods and treatment strategies for early IPF.

Transcranial focused ultrasound (tFUS) is an emerging modality for non-invasive brain stimulation and therapeutic intervention, offering millimeter-scale spatial precision and the ability to target deep brain structures. However, the heterogeneous and anisotropic nature of the human skull introduces significant distortions to the propagating ultrasound wavefront, which require time-consuming patient-specific planning and corrections using numerical solvers for accurate targeting. To enable data-driven approaches in this domain, we introduce TFUScapes, the first large-scale, high-resolution dataset of tFUS simulations through anatomically realistic human skulls derived from T1-weighted MRI images. We have developed a scalable simulation engine pipeline using the k-Wave pseudo-spectral solver, where each simulation returns a steady-state pressure field generated by a focused ultrasound transducer placed at realistic scalp locations. In addition to the dataset, we present DeepTFUS, a deep learning model that estimates normalized pressure fields directly from input 3D CT volumes and transducer position. The model extends a U-Net backbone with transducer-aware conditioning, incorporating Fourier-encoded position embeddings and MLP layers to create global transducer embeddings. These embeddings are fused with U-Net encoder features via feature-wise modulation, dynamic convolutions, and cross-attention mechanisms. The model is trained using a combination of spatially weighted and gradient-sensitive loss functions, enabling it to approximate high-fidelity wavefields. The TFUScapes dataset is publicly released to accelerate research at the intersection of computational acoustics, neurotechnology, and deep learning. The project page is available at https://github.com/CAMMA-public/TFUScapes.

The assessment of eosinophilic chronic rhinosinusitis (eCRS) lacks accurate non-invasive preoperative prediction methods, relying primarily on invasive histopathological sections. This study aims to use computed tomography (CT) images and clinical parameters to develop an integrated deep learning model for the preoperative identification of eCRS and further explore the biological basis of its predictions. A total of 1098 patients with sinus CT images were included from two hospitals and were divided into training, internal, and external test sets. The region of interest of sinus lesions was manually outlined by an experienced radiologist. We utilized three deep learning models (3D-ResNet, 3D-Xception, and HR-Net) to extract features from CT images and calculate deep learning scores. The clinical signature and deep learning score were inputted into a support vector machine for classification. The receiver operating characteristic curve, sensitivity, specificity, and accuracy were used to evaluate the integrated deep learning model. Additionally, proteomic analysis was performed on 34 patients to explore the biological basis of the model's predictions. The area under the curve of the integrated deep learning model to predict eCRS was 0.851 (95% confidence interval [CI]: 0.77-0.93) and 0.821 (95% CI: 0.78-0.86) in the internal and external test sets. Proteomic analysis revealed that in patients predicted to be eCRS, 594 genes were dysregulated, and some of them were associated with pathways and biological processes such as chemokine signaling pathway. The proposed integrated deep learning model could effectively predict eCRS patients. This study provided a non-invasive way of identifying eCRS to facilitate personalized therapy, which will pave the way toward precision medicine for CRS.